Profile
Michael Broxson is currently a Director at Molecular Templates OpCo, Inc. and a Vice President, Head-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. He was previously the Chief Executive Officer at Q32 Bio, Inc. and a Director at Molecular Templates, Inc. Broxson received an undergraduate degree from Tulane University (Louisiana) and an MBA degree from The University of Chicago Booth School of Business.
Michael Broxson active positions
| Companies | Position | Start |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | - |
Former positions of Michael Broxson
| Companies | Position | End |
|---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Chief Executive Officer | 20/09/2022 |
| MOLECULAR TEMPLATES, INC. | Director/Board Member | - |
Training of Michael Broxson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Michael Broxson
















